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Introduction
“Hemodialysis at the Beginning of the Next Millen- to normalize the “melieu interne.” Despite the limita-
nium: From Pathophysiology to Clinical Application” tions of urea, still it stands today as a powerful marker
seemed to us the right title for this Supplement issue to for assessing the kinetics of removal of all highly diffusive
Kidney International, and we need to briefly explain why. small molecular weight toxins. Over the years, different
The Guest Editors for this supplement have been eye approaches to model the dialysis dose have been pro-
witnessing developments in knowledge and technology posed since the National Cooperative Dialysis Study
that have greatly affected treatment in end-stage renal (NCDS). However, there is still great controversy about
disease (ESRD) patients. At the brink of the new millen- the model itself. We are grateful to Frank Gotch—the
nium, more than 40 years after the pioneering experi- father of mathematical modeling—for his contribution
ments of extracorporeal substitutive therapy for renal in this issue, which points out the inherent danger of
failure, we felt that a collection of key contributions in misunderstanding such model applications such as Kt/V,
various areas of pathophysiology and should reinforce, which clearly had an impact on the negative effects of
whenever possible, their clinical application, thus bridg- shifting dialysis time. We agree with him that, given the
ing the gap between research and the everyday practice disastrous effects of misinterpretation of the NCDS on
of attending nephrologists. Today, around one million hemodialysis therapy, we should allow him to explain at
ESRD patients are receiving renal replacement therapy length the reasons for these misinterpretations. In more
(with the majority of them being on hemodialysis), with recent years, also considering the availability of online
an incident number of 100 to 250 patients per million urea sensors and urea kinetic modeling, the description
population per year. The profile of the treated patients and recognition of some confounding factors have been
has changed over the years. Older patients with comor- reassessed with the hope of providing a closer look at
bidities are receiving treatment with the novel goal of dialysis efficiency. In the search for a broader approach
not only having a longer survival, but of having a more to adequacy in dialysis, an accurate description of “ure-
acceptable rehabilitation and quality of life. For some mic toxins” was thought to give a definitive and compre-
time, there has been a focus toward an emphasis on mem- hensive state-of-the-art of the many biologically relevant
branes, materials, machines, and modeling. This has been compounds that new technologies should aim at re-
particularly evident in certain geographic regions where moving.
technical aspects, mixed with economic and industrial A major issue in research has been in the concept of
factors, have overshadowed patient treatment. Recently, how and how much sodium and water should be removed
there has been a strong trend toward pathophysiology. in hemodialysis. While sodium and water are normally
When we started to select the areas in which research in both removed by the kidney throughout the day (with
the patient’s pathophysiology have provided key achieve- a perfect balance achieved within a short period of time
ments, we fully agreed on three main areas: the removal and a perfect maintenance of plasma osmolality and cell
of urea and other uremic toxins, the correction of sodium volume), in anuric patients, only hemodialysis is able to
and water overload, and finally, the clinical relevance of normalize the abnormal sodium balance. The impor-
chronic inflammation, particularly in the context of the tance of adequate estimation of sodium and water in
possible links to enhanced risk of mortality and morbid- body fluids is commonly observed in clinical practice.
ity from cardiovascular disease and malnutrition. Excessive or insufficient removal of sodium and water
Uremia is an as yet unknown pathophysiological en- inevitably leads to the appearance of well-known side
tity. It describes an overall state of accumulation of a effects both intradialytically and interdialytically. The
large number of solutes that are normally cleared by the results from intensive research on sodium modeling and
glomerular or tubular function. Some of these solutes the homeostasis among the different body compartments
have concentration-dependent toxicity and have merited
cannot be underestimated, since these comprise the fun-
the general term of “uremic toxins.” The rationale of
damental basis for improving hemodynamic stabilitythe hemodialysis therapy is the removal of these toxins
during dialysis, a better blood pressure control, and the
cardiovascular status. Cardiovascular disease is the lead-
Received for publication April 11, 2000 ing cause of death among ESRD patients, with the risk
being 10 to 20 times higher than that observed in age-Ó 2000 by the International Society of Nephrology
S-1
IntroductionS-2
and sex-matched healthy population. A comprehensive as low serum albumin, high plasma C-reactive protein,
and increased oxidized low-density lipoprotein. Chronicreview on the cardiovascular alterations most commonly
found in ESRD patients acquaints the reader with the inflammation has a rather wide implication in anemia as
well as malnutrition. Thus, comprehensive reviews onpathophysiologic mechanisms that both lead to their ap-
pearance and worsening in the medium and long term. production of proinflammatory cytokines and on the
mechanisms relating their enhanced synthesis to highHemodynamic factors and atherosclerotic and nonath-
erosclerotic lesions form a complex mosaic of histopatho- plasma levels of C-reactive protein and anti-inflamma-
tory interleukins are incorporated in this issue to empha-logic alterations such as diffuse coronary artery disease,
left ventricular hypertrophy, and reduced arterial com- size the relevance of quality of dialysis fluid as a manda-
tory requirement for today’s treatment.pliance because of aortic and other arterial lesions. Fur-
thermore, hemodialysis may contribute to trigger and Evidence is now largely accumulating that both uremia
per se and the hemodialysis treatment may be involved into maintain accelerated atherosclerosis via the overall
inadequate removal of the previously mentioned solutes, clinically relevant sequelae that occur in today’s ESRD
population. The nutritional state remains a key questionbut also via the system’s bioincompatibility.
End-stage renal disease patients show evidence of a that deserves special attention, particularly in the predia-
lytic stage, as well as when the patient is in hemodialysis.chronic inflammatory state. Oxidation-derived products
At the end of all of the contributions, we have highlightedsuch as those derived from advanced glycation of both
the consensus that may be found in the dialysis commu-lipids and proteins are increased in chronic renal failure
nity. When this was not possible, both sides of the ongo-and even more in hemodialysis patients. Much evidence
ing controversies are presented, with the aim of leavingpoints to the fact that biologically-active oxidized lipid
the reader make the final conclusion.and protein products are not only markers of oxidative
We can only hope that our efforts are successful atstress, but also novel mediators of the vessel and tissue
least on one point: to convince the reader that hemodial-damage, thus favoring the development of arterial abnor-
ysis is still an area of intensive research. Any attempt tomalities. A question has been around for years: Why is
fix “gold standards” could be only too simplistic. Thereit that hemodialysis is associated with accelerated athero-
should be no slowdown in the concerted action for bettersclerosis? Part of the answer relies on the concept of
knowledge. We hope that more research and promptan enhanced cytokine response in ESRD patients. A
transfer of new acquisitions to dialysis treatment maydetailed review covers the various pathophysiological
occur in the third millennium.aspects in which an unbalanced production of these cell-
We are indebted to and sincerely thank all of theto-cell mediators is thought to play a role in clinically
distinguished contributors who accepted our request forrelevant complications in hemodialysis patients. How-
them to elaborate on their specific area of expertise inever, only recently, a more precise link between the bio-
terms understandable to the entire dialysis communityincompatibility-associated phenomena and the triggering
and, in some cases, to submit original data. A specialof mechanisms known to occur as part of the acute phase
thank you is given to Bellco for sponsoring the publica-response was given. This knowledge, together with the
tion expenses of this Supplement, and to Dr. Ciro Tettaincreased awareness of inflammation in the pathogenesis
for the scientific support given to us.of initial lesions at the level of the vessel wall leading to
plaque formation, has provoked great interest in the Giuseppe La Greca, Horst Klinkmann,
achievement of new technologies and dialytic strategies Fernando Valderra´bano, and Pietro Zucchelli
Guest Editorsthat may normalize strong independent risk factors such
